Tayebeh Roghani | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Tayebeh Roghani | Medicine and Dentistry | Best Researcher Award

Assistant Professor of Physical Therapy from Isfahan University of Medical Sciences, Iran

Dr. Tayebeh Roghani is an accomplished Assistant Professor at the Department of Physiotherapy, Faculty of Rehabilitation Sciences, Isfahan University of Medical Sciences, Iran. With over a decade of academic, clinical, and research experience, she has made significant contributions to the field of physiotherapy, especially in the areas of musculoskeletal aging and osteoporosis. Her career has been driven by a deep commitment to improving physical health outcomes for aging populations through evidence-based physiotherapeutic interventions. She has authored numerous peer-reviewed articles, systematic reviews, and book translations. Her scholarly contributions focus primarily on hyperkyphosis, balance, gait, postural control, and back muscle function, with a particular emphasis on older women. Dr. Roghani is also actively engaged in mentoring MSc students and supervising academic research projects, further demonstrating her role in fostering the next generation of rehabilitation scientists. She has participated in local and international congresses, presented both oral and poster presentations, and has acted as a peer reviewer for prestigious scientific journals. Her academic rigor, research productivity, and teaching excellence make her a standout in her field, and she is widely respected for her methodological approach to research and dedication to the advancement of physiotherapy education and practice.

Professional Profile

Education

Dr. Roghani began her academic journey in 2003 at Isfahan University of Medical Sciences, where she earned her Bachelor of Science (B.S) in Physiotherapy in 2007. Building on her foundational knowledge, she pursued her Master of Science (M.Sc.) in Physiotherapy at Tarbiat Modares University, Tehran, from 2008 to 2011. Her graduate research deepened her understanding of therapeutic methods and patient rehabilitation. She later advanced her academic qualifications by obtaining a Ph.D. in Physiotherapy from Shahid Beheshti University of Medical Sciences, Tehran, in 2017. Her doctoral work primarily investigated osteoporosis, aging-related hyperkyphosis, and associated motor control disorders in postmenopausal women. Throughout her academic training, she participated in numerous workshops and specialized courses, including ISI paper writing, systematic reviews, SPSS data analysis, and neurorehabilitation techniques. These academic milestones have equipped her with robust research capabilities and a strong theoretical foundation. Her progressive academic path, from undergraduate to doctoral studies, highlights her sustained commitment to advancing the scientific understanding of physiotherapy and promoting improved clinical interventions. Dr. Roghani’s education is not only comprehensive but also strategically aligned with her research interests and teaching roles, making her an influential academic figure in the rehabilitation sciences.

Professional Experience

Dr. Tayebeh Roghani has cultivated a distinguished professional career as a physiotherapist, academic, and researcher. Currently an Assistant Professor at Isfahan University of Medical Sciences (IUMS), she has played a key role in both clinical education and research supervision. Since 2014, she has taught numerous undergraduate and postgraduate courses, including hospital internships, therapeutic exercise, evidence-based physiotherapy, and electromyography. Her academic appointments span both Shahid Beheshti University of Medical Sciences and IUMS, reflecting her versatility and recognition across major institutions. Beyond teaching, she serves as an examiner for MSc proposals and theses, evaluating research on osteoarthritis, chronic pain, stroke rehabilitation, and more. Dr. Roghani has also contributed extensively to university-approved research projects focusing on back muscle function, hyperkyphosis, and menopause-related musculoskeletal changes. Her active role in departmental planning, curriculum development, and grand rounds further solidifies her academic leadership. Notably, she has reviewed scientific articles for reputed journals such as PLOS One and Osteoporosis International. Her professional trajectory reflects a blend of academic excellence, clinical insight, and research-driven innovation, positioning her as a leader in advancing rehabilitation practices and physiotherapy education in Iran and beyond.

Research Interest

Dr. Roghani’s primary research interests lie at the intersection of aging, musculoskeletal health, and physiotherapeutic intervention. Her research is focused on age-related hyperkyphosis, osteoporosis, motor control, and the physical functioning of older adults. She is particularly interested in understanding how spinal deformities and muscle imbalances influence postural stability, gait, and balance. Her work has extended into randomized controlled exercise trials to evaluate the effectiveness of aerobic and resistance training—both with and without external loading—on improving bone metabolism and physical fitness in postmenopausal women. Another significant area of her research is the assessment and enhancement of back extensor muscle function in individuals with age-related spinal curvature. She also investigates the clinical implications of musculoskeletal variables on abdominal bloating and gait speed in women experiencing menopause. Her approach is both experimental and evidence-based, often involving cross-sectional and comparative designs as well as systematic reviews and meta-analyses. Collaborating with both national and international researchers, she aims to translate clinical observations into scientifically validated treatment approaches. Her research not only adds depth to physiotherapy literature but also contributes to the development of effective, non-invasive interventions for aging populations.

Research Skills

Dr. Tayebeh Roghani brings a diverse set of research skills to the field of physiotherapy and rehabilitation sciences. Her proficiency includes designing and conducting randomized controlled trials, performing systematic reviews, and carrying out meta-analyses. She is well-versed in using statistical software such as SPSS for quantitative data analysis and has experience with MATLAB for modeling and simulation. Dr. Roghani is skilled in both clinical and experimental research methodologies, including biomechanical assessments, electromyography, and gait analysis. She has developed validated instruments to assess static back extensor strength and spinal curvature, enhancing reliability in clinical trials involving older women. Her understanding of hormonal biomarkers and their relationship to physical function adds a multidisciplinary edge to her research. She has also been trained in ethical research practices, data interpretation, and evidence-based protocol development. As a peer reviewer for international journals, she evaluates scientific manuscripts with a keen eye for methodological rigor and clarity. Dr. Roghani’s comprehensive research toolkit enables her to carry out robust investigations that bridge the gap between theory and clinical application, ultimately contributing to improved patient outcomes in musculoskeletal and geriatric rehabilitation.

Awards and Honors

Dr. Tayebeh Roghani has been the recipient of notable academic honors that recognize her commitment to excellence in physiotherapy education and research. During her doctoral studies, she was awarded the Ph.D. Student Distinguished Achievement Award in both the 9th and 10th Shahid Motahari Educational Festivals in 2014 and 2015 respectively. These prestigious awards are given to outstanding students who demonstrate exceptional academic performance, research quality, and educational leadership. The recognition reflects her strong dedication to physiotherapy as a scientific discipline and highlights her early contributions to the field, even before completing her Ph.D. Beyond these accolades, her selection as a peer reviewer for high-impact journals such as PLOS One, Osteoporosis International, and Physiotherapy Theory and Practice indicates professional recognition of her scholarly expertise. These honors, coupled with her institutional project approvals and invited academic roles, affirm her status as a leading academic and a role model within the field of rehabilitation sciences. Dr. Roghani’s career trajectory is marked not just by her achievements but by the consistent recognition of her excellence by peers, mentors, and academic institutions alike.

Conclusion

Dr. Tayebeh Roghani stands out as a dedicated and accomplished scholar whose contributions to the field of physiotherapy have had meaningful impact both in academia and clinical practice. With a strong educational foundation, impressive publication record, and a clear focus on aging-related musculoskeletal conditions, she brings depth, precision, and relevance to her research. Her ability to bridge theoretical knowledge with practical application positions her as a valuable asset in developing innovative rehabilitative approaches. Moreover, her role as a teacher, mentor, and examiner demonstrates her commitment to fostering the next generation of healthcare professionals. She is actively involved in collaborative research and maintains strong ties with institutional and international peers. While she has already achieved much, there remains significant potential for future growth through expanded global collaborations, grant acquisition, and continued interdisciplinary exploration. In summary, Dr. Roghani exemplifies the attributes of an outstanding researcher—rigorous, ethical, collaborative, and visionary. Her sustained efforts make her a highly suitable candidate for the Best Researcher Award, and her ongoing work promises continued advancements in rehabilitation science and physiotherapy for aging populations.

Publications Top Notes

  1. Comparison of Back Extensor Muscle Function in Older Males With and Without Age-Related Hyperkyphosis: A Protocol Study
    Journal: The Scientific Journal of Rehabilitation Medicine, 2025
    Authors: Anahita Vahdati, Hoda Niknam, Tayebeh Roghani

  2. Spinal‐Related Musculoskeletal Determinants of Functional Abdominal Bloating and Distension: A Narrative Review
    Journal: Health Science Reports, 2025
    DOI: 10.1002/hsr2.70976
    Authors: Rezvan Ghomash Baf Zadeh, Tayebeh Roghani, Amy Gladin, Wendy B. Katzman, Fateme Bokaee, Peyman Adibi

  3. Associations Between Menopause Status, Spinal-Related Musculoskeletal Variables and Gait Speed in Middle-Aged Females: A Short Report
    Journal: Musculoskeletal Care, 2024
    Authors: Faezeh Fatehi, Tayebeh Roghani, Azam Zafarbakhsh, Amy Gladin, Fateme Bokaee, Najimeh Tarkesh Isfahani, Ibrahim Abdollahpour, Hoda Niknam, Motahar Heidari-Beni, Wendy B. Katzman

  4. Comparison of Postural Balance, Muscle Force and Spinal Posture in Obese Children and Adolescents – A Protocol Study
    Journal: Iranian Journal of Diabetes and Obesity, 2024
    Authors: Fateme Reysy, Fateme Bokaee, Tayebeh Roghani, Grace O’Malley, Najimeh Tarkesh Esfahani, Motahar Heidari Beni, Roya Kelishadi

  5. Investigating the Difference Between Thoracic Kyphosis and Its Mobility in Community-Dwelling Older Men and Women
    Journal: Journal of Modern Rehabilitation, 2024
    Authors: Somayeh Mahmoodiaghdam, Maryam Nodehi, Himan Aryanfar, Tayebeh Roghani, Alireza Akbarzadeh Baghban, Minoo Khalkhali Zavieh

  6. Short and Medium-Term Effects of Kinesio Taping on Proprioception After Anterior Cruciate Ligament Reconstruction
    Journal: The Scientific Journal of Rehabilitation Medicine, 2024
    Authors: Tayebeh Roghani, Hoda Niknam, Mehdi Rezaei, Narges Jahantigh Akbari, Ali Asghar Jame Bozorgi

  7. The Association Between Physical Function and Hyperkyphosis in Older Females: A Systematic Review and Meta-Analysis
    Journal: Journal of Geriatric Physical Therapy, 2024
    Authors: Tayebeh Roghani, Diane D. Allen, Amy Gladin, Alireza Rahimi, Marziyeh Mehrabi, Zahra Sadat Rezaeian, Ziba Farajzadegan, Wendy B. Katzman

  8. The Comparison of Musculoskeletal Variables in Females With and Without Functional Abdominal Bloating: A Protocol Study
    Journal: Journal of Rehabilitation Sciences and Research, 2024
    Authors: Rezvan Ghomash Baf Zadeh, Tayebeh Roghani, Mostafa Raisi, Ibrahim Abdollahpour, Fateme Bokaee, Najimeh Tarkesh Isfahani, Seyed Mohsen Mirbod, Motahar Heidari-Beni, Peyman Adibi

Juncheng Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Mr. Juncheng Zhang | Medicine and Dentistry | Best Researcher Award

Doctor from Gansu Maternal and Child Health Care Hospital (Gansu Provincial Central Hospital), China

Dr. Juncheng Zhang is a highly experienced gynecologist with over 12 years of dedicated service in the field of obstetrics and gynecology. Currently serving as a Gynaecologist-in-charge, he has built a clinical and research career centered around women’s reproductive health, with a strong focus on cancer immunotherapy. His primary academic interest lies in the development of innovative immunotherapeutic treatments for cervical cancer, particularly adoptive cell therapy. Dr. Zhang has recently contributed to scholarly literature through a publication in the International Journal of Gynaecology & Obstetrics, underscoring his commitment to research-driven clinical advancements. Although his citation index and collaborations are still in development, his work presents significant potential for future impact in both academic and clinical communities. Dr. Zhang is recognized for his analytical thinking, patient-centered care, and efforts to bridge clinical practice with medical research. His self-motivation and commitment to continuous learning make him a valuable contributor to the medical field. With further opportunities for research collaborations and publication expansion, Dr. Zhang is on track to become a leading expert in immunotherapy for gynecological cancers. His emerging research profile demonstrates both promise and dedication to improving outcomes for patients affected by cervical cancer.

Professional Profile

Education

Dr. Juncheng Zhang’s educational foundation is rooted in medical science, with specialized training in obstetrics and gynecology. Although specific degree titles and institutions were not mentioned in his nomination form, it is clear that his qualifications have enabled him to serve as an attending physician in a clinical setting for over a decade. Typically, such a career trajectory involves earning a Bachelor of Medicine degree (MBBS or equivalent), followed by a residency or postgraduate specialization in gynecology and obstetrics. His academic background has equipped him with in-depth knowledge in both reproductive health and advanced medical interventions, particularly in the area of oncological gynecology. Dr. Zhang’s continued interest in research further reflects the academic rigor he has maintained throughout his professional development. The progression from medical training to research in immunotherapy suggests that he has received not only clinical training but also exposure to scientific research methodologies. As he continues to publish in indexed journals and engage in specialized research, it is likely that Dr. Zhang is either actively engaged in or planning to pursue further academic qualifications, such as a Master’s or Doctorate in a related field. This combination of clinical and research education forms a strong foundation for his contributions to women’s healthcare.

Professional Experience

Dr. Juncheng Zhang has amassed over 12 years of professional experience in the field of obstetrics and gynecology, currently holding the position of Gynaecologist-in-charge. His clinical responsibilities include managing women’s reproductive health, diagnosing and treating gynecological conditions, and performing both routine and complex procedures. Over the years, he has developed a profound understanding of the physiological and pathological aspects of gynecological diseases. In parallel to his clinical practice, Dr. Zhang has cultivated a strong research interest in cervical cancer, leading him to pursue scientific investigation alongside patient care. His dual role as a physician and a researcher has enabled him to directly translate clinical observations into research questions, fostering a pragmatic and relevant approach to medical research. His professional journey is marked by a transition into cancer immunotherapy, particularly the use of adoptive cell therapies, where he seeks to explore novel treatments for one of the most challenging diseases affecting women. Despite limited experience in industry consultancy or editorial roles, Dr. Zhang’s clinical leadership and emerging research credentials establish him as a dedicated and evolving professional in the medical community. His ongoing publication activity indicates a promising future trajectory, blending clinical excellence with research innovation.

Research Interests

Dr. Zhang’s primary research interests center on cervical cancer immunotherapy, a field that integrates immunology, oncology, and clinical medicine. He is particularly focused on adoptive cell therapy, which involves enhancing the body’s immune response by administering immune cells engineered or activated outside the body. This therapeutic strategy is gaining traction in cancer treatment and holds specific promise for cervical cancer, a disease with considerable global morbidity. His work on the role of CD3 and CD28 in cervical cancer cell proliferation and their impact on peripheral blood mononuclear cell (PBMC) invasion mechanisms reflects a molecular approach to understanding and combating cancer progression. Dr. Zhang aims to contribute to the scientific community by identifying innovative therapeutic pathways that improve treatment outcomes and reduce recurrence. His research bridges the gap between laboratory science and clinical application, contributing valuable knowledge to translational medicine. The use of tumor-infiltrating lymphocytes in treatment design is an especially promising avenue, and Dr. Zhang is actively exploring how this strategy can be tailored to individual patients. His focus aligns with international efforts to enhance targeted therapy and reduce treatment resistance in gynecologic oncology, and he is committed to advancing this research area through publication and potential clinical trials.

Research Skills

Dr. Juncheng Zhang demonstrates a strong command of essential research skills critical for biomedical innovation. His ability to design, execute, and analyze experiments involving immunotherapy mechanisms positions him as a competent translational researcher. He has practical experience in evaluating the roles of immune markers such as CD3 and CD28 in tumor biology, reflecting a solid grasp of molecular biology techniques. Dr. Zhang’s recent publication in an indexed journal illustrates his proficiency in scientific writing and literature synthesis. His knowledge of adoptive cell therapies further underscores familiarity with cutting-edge cancer treatment modalities and laboratory processes involved in cell preparation, expansion, and activation. Additionally, Dr. Zhang appears adept at hypothesis generation based on clinical challenges, a vital research skill that supports the development of impactful investigations. While his exposure to citation metrics and interdisciplinary collaborations may still be developing, the depth of his subject-specific expertise provides a strong foundation for future growth. As he continues to refine his research methodology and expand his publication record, Dr. Zhang is well-positioned to make significant contributions to the field of gynecologic oncology. His integrated skill set allows him to navigate both the clinical and research environments effectively, ensuring that his scientific work remains practically relevant.

Awards and Honors

While Dr. Juncheng Zhang has not listed specific awards or honors in his nomination form, his selection for consideration in the Best Researcher Award itself reflects growing recognition of his contributions to the field of cervical cancer immunotherapy. Emerging researchers often begin their award journey through peer-reviewed publications and conference presentations, milestones Dr. Zhang has started to achieve. His first major publication in a prestigious indexed journal suggests he is gaining visibility in the academic and clinical research communities. As his research matures and gains citation traction, opportunities for awards, fellowships, and research grants will likely follow. In many cases, clinician-researchers such as Dr. Zhang are recognized for bridging the gap between practice and innovation—a commendable achievement in itself. Awards in this domain typically follow impactful clinical trials, translational research breakthroughs, or innovations in patient care. With continued publication, collaborative projects, and deeper involvement in research societies, Dr. Zhang will be well-placed to receive formal honors from medical associations, academic institutions, and healthcare innovation platforms. His trajectory indicates strong potential for future awards as he builds upon his existing foundation of scientific and clinical excellence.

Conclusion

Dr. Juncheng Zhang is a promising clinician-researcher whose dedication to improving women’s healthcare through scientific innovation is clearly evident. With over a decade of experience as a gynecologist, he brings real-world clinical insights into the research laboratory, allowing for impactful, patient-centered investigation. His focused interest in cervical cancer immunotherapy, particularly in adoptive cell therapy, reflects a cutting-edge approach that aligns with global priorities in cancer research. Though his academic portfolio is still in its early stages, his first publication marks a critical step in establishing his presence in the research community. His methodological clarity, clinical depth, and strong motivation make him an ideal candidate for advanced recognition. While areas such as citation impact, professional society involvement, and collaboration are yet to be expanded, the foundations for a successful and influential research career are firmly in place. Continued publication, increased engagement in academic circles, and involvement in translational trials could significantly elevate his profile. In conclusion, Dr. Zhang is a valuable asset to the field of gynecologic oncology, and with the right opportunities and support, he has the potential to emerge as a leading figure in cancer immunotherapy research.

Publications Top Notes

  1. 🩺 Title: A rare case of pregnancy in a type II unicornuate uterus
    Journal: Asian Journal of Surgery
    Date: May 2025
    Authors: Juncheng Zhang, Yafei Wang, Hongfang Li

  2. 🦠 Title: A rare case of squamous cell carcinoma of the ovary
    Journal: Asian Journal of Surgery
    Date: May 2025
    Authors: Juncheng Zhang, Yafei Wang, Jianping Sun, Hongfang Li

Risa Yamada | Health Professions | Best Researcher Award

Published on by Shen Awards

Ms. Risa Yamada | Health Professions | Best Researcher Award

Researcher from National Center of Neurology and Psychiatry, Japan

Risa Yamada is an esteemed Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan. Her research primarily focuses on neuropsychopharmacology, epidemiology, and neurophysiology in patients with psychiatric disorders such as schizophrenia, mood disorders, and substance abuse. She is renowned for her pioneering work in the epidemiology of gambling disorders, exploring the impact of comorbid behavioral addiction. Her research has yielded significant insights into the effectiveness of serotonin-5-HT1A receptor partial agonists for cognitive enhancement in schizophrenia, with findings published in prestigious journals. Additionally, she is conducting cutting-edge research on transcranial photobiomodulation to ameliorate cognitive deficits in schizophrenia. Yamada has made notable contributions to the understanding of depression severity and the role of adverse childhood experiences in mood disorders. With a background in clinical psychology and neuropsychopharmacology, she is a rising leader in the field of psychiatric research.

Professional Profile

Education

Risa Yamada completed her medical education at the Jikei University School of Medicine, earning her Ph.D. in February 2023. Prior to this, she received a Bachelor of Science degree from Toho University in 2011 and a Master of Psychology from Teikyo University in 2018. Throughout her educational journey, she focused on the intersection of clinical psychology and psychiatry, particularly in understanding the neuropsychological aspects of psychiatric disorders. Her academic development laid a strong foundation for her subsequent research career. In addition to her medical degrees, Yamada holds certifications as a Clinical Psychologist (2019) and a Public Psychologist (2019), which further demonstrate her expertise and commitment to advancing psychological and psychiatric research. These educational qualifications, coupled with her practical research experience, allow Yamada to contribute significantly to the development of new treatment strategies for psychiatric conditions, particularly those related to cognitive dysfunction and behavioral addictions.

Professional Experience

Risa Yamada currently serves as the Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders at the National Institute of Mental Health, part of the National Center of Neurology and Psychiatry in Tokyo, Japan. She has been in this role since September 2021 and has been instrumental in leading research focused on cognitive impairments in psychiatric conditions such as schizophrenia. Yamada’s career began as a Research Associate in the Department of Mental Disorder Research at the National Center of Neurology and Psychiatry from 2018 to 2021, where she investigated depression severity and its links to adverse childhood experiences and coping styles. Prior to her current position, she conducted a doctoral research project at Jikei University, where she explored the relationship between gambling disorder and psychiatric conditions. Her extensive experience spans multiple research settings, with her work having a significant impact on clinical understanding and treatment development for various psychiatric conditions. Yamada’s role as a researcher and educator also extends to her involvement in several leading academic societies in psychiatry and neuropsychopharmacology.

Research Interests

Risa Yamada’s research interests lie at the intersection of clinical psychology, psychiatry, and neuropsychopharmacology. She is deeply engaged in studying the cognitive and neurophysiological aspects of psychiatric disorders, particularly schizophrenia, mood disorders, and behavioral addictions such as gambling disorders. Her work focuses on the use of neuropsychological methods to explore the biological and psychological underpinnings of these conditions, with a particular emphasis on cognitive impairment. One of her notable research projects involves studying the augmentation of cognitive function in schizophrenia using serotonin-5-HT1A receptor partial agonists, a promising avenue for improving psychotic symptoms and cognitive deficits. Additionally, Yamada is investigating the potential of transcranial photobiomodulation, a non-invasive brain stimulation technique, to address cognitive impairments in patients with schizophrenia. She also explores the relationship between adverse childhood experiences and mood disorders, with the goal of identifying effective biomarkers and treatments for negative valence in psychiatric conditions. Her research aims to advance both theoretical understanding and practical interventions for these prevalent and challenging mental health conditions.

Research Skills

Risa Yamada possesses a diverse and advanced skill set in clinical research, particularly in the fields of neuropsychopharmacology, epidemiology, and neurophysiology. She is proficient in conducting meta-analyses and cross-sectional studies, particularly related to psychiatric disorders and cognitive dysfunction. Her expertise in neuropsychological methods allows her to investigate complex interactions between psychological traits and psychiatric conditions. Yamada is skilled in using clinical scales and neurophysiological tools, such as skin conductivity measures, to assess psychological traits like interoception and alexithymia in relation to psychiatric conditions. Furthermore, she has experience in neuroimaging techniques, including the use of transcranial photobiomodulation for brain stimulation. Yamada’s work with behavioral addiction, particularly gambling disorders, demonstrates her ability to apply epidemiological methods to mental health research. She is also adept at analyzing large-scale clinical data sets and using statistical models to explore the relationship between psychiatric symptoms and demographic variables. These research skills enable her to lead impactful studies that contribute both to the scientific community and to practical applications in the treatment of psychiatric disorders.

Awards and Honors

Risa Yamada has received recognition for her contributions to psychiatric research, particularly in the areas of neuropsychopharmacology and behavioral addiction. She has been awarded several academic honors, including recognition for her groundbreaking research on gambling disorders, which was the first of its kind in Japan. Her work on cognitive enhancement therapies for schizophrenia has been published in high-impact journals, earning her a reputation as a leader in the field. While she has not yet received large-scale awards, her growing recognition within the academic community and her role as Chief Researcher at the National Institute of Mental Health reflect her increasing influence. Yamada’s contributions to psychiatric research have been acknowledged through invitations to present her findings at prestigious international conferences. She is also a member of several leading professional societies, including the Collegium Internationale Neuro-Psychopharmacologicum and the Japanese Society of Neuropsychopharmacology, further solidifying her status as a respected researcher.

Conclusion

Risa Yamada is a highly promising and accomplished researcher in the field of psychiatry, with a focus on neuropsychopharmacology, neurophysiology, and epidemiology. Her work has already made a significant impact, particularly in the understanding of cognitive dysfunction in schizophrenia and gambling disorders. With a robust educational background and extensive professional experience, Yamada is well-positioned to continue contributing to the advancement of psychiatric research. Her innovative approach to non-invasive brain stimulation, alongside her focus on biomarkers for psychiatric conditions, highlights her potential for further breakthroughs. While her research is primarily centered on schizophrenia and mood disorders, expanding her focus to other psychiatric conditions would enhance the breadth of her contributions. With continued growth in international collaboration and further emphasis on translational research, Yamada has the potential to make a lasting impact on both clinical practice and scientific understanding in the field of psychiatry.

Publications Top Notes

  • Clinical Significance of Psychiatric Comorbidities Among Outpatients With Gambling Disorder in Japan: A 12-Month Follow-Up Study
    Authors: Yamada, R., Stickley, A., Shigeta, M., Miyata, H.
    Year: 2025

  • Semantic memory disorganization linked to social functioning in patients with schizophrenia
    Authors: Wada, A., Sumiyoshi, C., Yoshimura, N., Hashimoto, R., Matsumoto, J., Stickley, A., Yamada, Y., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Yamada, R., Sumiyoshi, T.
    Year: 2025

  • Autistic trait severity in early schizophrenia: Role in subjective quality of life and social functioning
    Authors: Wada, A., Yamada, R., Yamada, Y., Sumiyoshi, C., Hashimoto, R., Matsumoto, J., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Stickley, A., Yoshimura, N., Sumiyoshi, T.
    Year: 2025

  • Problematic gambling and psychotic-like experiences: Findings from Japan
    Authors: Stickley, A., Shirama, A., Yamada, R., Sumiyoshi, T.
    Year: 2024

  • Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Prevalence and Clinical Significance of Psychiatric Comorbidities With Gambling Disorder in 12 Clinical Settings in Japan
    Authors: Yamada, R., Miyashita, K., Hashimoto, T. M., et al.
    Year: 2023

  • Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
    Authors: Yamada, R., Fujii, T., Hattori, K., et al.
    Year: 2023

  • The relationship between severity of drug problems and perceived interdependence of drug use and sexual intercourse among adult males in drug addiction rehabilitation centers in Japan
    Authors: Yamada, R., Shimane, T., Kondo, A., Yonezawa, M., Matsumoto, T.
    Year: 2021

Didem Tezen | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Didem Tezen | Medicine and Dentistry | Best Researcher Award

Istanbul University- Cerrahpasa, Cerrahpasa Faculty of Medicine, Turkey

Dr. Didem Tezen is a dedicated neurologist and researcher with a strong academic background and extensive experience in clinical neurology. She has contributed significantly to the field through her research on neuromuscular disorders, dementia, movement disorders, and neurogenetics. With multiple publications in reputable journals, she has demonstrated expertise in both clinical and molecular neuroscience. Dr. Tezen’s research focuses on the genetic and biochemical mechanisms underlying neurological diseases, aiming to advance diagnostic and therapeutic approaches. She has worked at prestigious institutions, including Istanbul University-Cerrahpaşa and Bakırköy Dr. Sadi Konuk Training and Research Hospital, and currently serves at Oltu State Hospital in Erzurum, Turkey. Her work is highly regarded for its impact on understanding rare neuromuscular syndromes, neuroinflammatory pathways, and neurodegeneration. She actively collaborates with leading experts in neurology and has played a key role in pioneering studies on biomarkers for dementia and genetic mutations in movement disorders. Dr. Tezen’s commitment to scientific discovery and her clinical expertise make her a valuable contributor to the field of neurology. Her growing international presence and dedication to translational research place her among the emerging leaders in neurological research and patient care.

Professional Profile

Education

Dr. Didem Tezen has pursued a distinguished academic journey in medicine and neurology, building a solid foundation for her research and clinical practice. She completed her medical education at Istanbul University, Istanbul Faculty of Medicine from 2011 to 2017, where she developed her fundamental medical knowledge and clinical skills. After graduating, she advanced her expertise by specializing in neurology at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, between 2018 and 2024. This rigorous residency program provided her with extensive experience in managing a wide range of neurological conditions, including neurodegenerative diseases, neuromuscular disorders, and cerebrovascular diseases. During her studies, she actively participated in clinical research projects and collaborated with experienced faculty members, allowing her to gain practical knowledge in neurophysiology, neuroimaging, and genetic neurology. Her educational background has played a crucial role in shaping her research interests, particularly in biomarker discovery, genetic analysis, and neuroinflammatory mechanisms in neurological disorders. Currently, she continues to apply her knowledge and expand her expertise as a practicing neurologist, while also engaging in ongoing research in her field. Her academic achievements and commitment to lifelong learning highlight her dedication to advancing neurological science and patient care.

Professional Experience

Dr. Didem Tezen has accumulated extensive clinical and research experience throughout her career in neurology. She began her professional journey at Bakırköy Dr. Sadi Konuk Training and Research Hospital, where she worked from 2017 to 2018, gaining firsthand experience in diagnosing and treating a variety of neurological conditions. This period provided her with essential clinical skills and exposure to neurology emergencies and complex neurological disorders. From 2018 to 2024, she further honed her expertise at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Neurology Department, where she was involved in both clinical neurology and research. During this time, she contributed to several groundbreaking studies focusing on neurodegenerative diseases, neuromuscular disorders, and molecular neurology. She collaborated with esteemed researchers and specialists in neurophysiology, genetics, and electrophysiology, leading to several high-impact publications. As of 2024, Dr. Tezen has been serving as a neurologist at Oltu State Hospital in Erzurum, Turkey, where she continues to provide specialized care to patients with complex neurological disorders. Her clinical expertise, combined with her strong research background, allows her to integrate the latest scientific advancements into patient treatment, making her a highly valued physician and researcher in the field of neurology.

Research Interests

Dr. Didem Tezen’s research interests are primarily focused on the genetic and biochemical mechanisms of neurological diseases, aiming to improve both diagnostic and therapeutic approaches. One of her key areas of interest is neurodegeneration, particularly the role of biomarkers and neuroinflammatory pathways in dementia and Alzheimer’s disease. Her research has explored the clinical significance of YKL-40, VILIP-1, and inflammatory cytokines in neurodegenerative disorders, shedding light on their potential use as biomarkers for disease progression. She is also deeply engaged in studying neuromuscular diseases, with a focus on congenital myasthenic syndromes, hereditary polyneuropathies, and motor neuron diseases. Her investigations into genetic mutations associated with these disorders have provided critical insights into their pathophysiology. Additionally, she has contributed to research on movement disorders, examining rare cases of ADCY5 gene mutations and cerebrotendinous xanthomatosis. Dr. Tezen is also interested in clinical neurophysiology, particularly the application of electromyography (EMG) and nerve conduction studies in diagnosing neuromuscular and movement disorders. Her multidisciplinary approach, integrating genetics, neuroinflammation, and electrophysiology, positions her as a forward-thinking researcher in the field of neurology.

Research Skills

Dr. Didem Tezen possesses a diverse set of research skills that enable her to conduct high-quality scientific investigations in neurology. She is proficient in neurogenetics, with expertise in analyzing genetic mutations related to neuromuscular diseases and movement disorders. Her ability to integrate molecular genetics and clinical findings has significantly contributed to understanding rare neurological conditions. She is also skilled in biomarker research, particularly in the context of dementia and neurodegeneration. Her experience in measuring serum biomarkers, neuroinflammatory markers, and neurodegenerative proteins has advanced the field’s understanding of disease progression and potential treatment targets. In clinical neurophysiology, she has expertise in performing and interpreting electrophysiological tests, such as EMG and nerve conduction studies, which are essential for diagnosing neuromuscular disorders. Additionally, her research involves advanced neuroimaging techniques, including MRI analysis of brain volume changes in dementia patients. Her ability to design clinical studies, analyze statistical data, and collaborate with interdisciplinary teams further enhances her research capabilities. Her strong academic writing skills have also enabled her to publish multiple research papers in peer-reviewed journals, reinforcing her reputation as an accomplished researcher.

Awards and Honors

Dr. Didem Tezen has been recognized for her outstanding contributions to neurology research through several awards and honors. She has received institutional recognition for her work in biomarker discovery and neurogenetics, contributing to a deeper understanding of neurodegenerative and neuromuscular disorders. Her research on biomarkers in dementia and neuroinflammatory pathways has been highly regarded in neurology conferences and academic circles. She has also played a key role in multi-disciplinary research teams that have advanced the field of neuromuscular genetics. In addition to her scientific achievements, Dr. Tezen’s clinical excellence and commitment to patient care have earned her commendations from senior neurologists and faculty members. Her dedication to both research and clinical neurology sets her apart as a well-rounded physician-scientist. With her growing body of work and increasing international presence, she is poised to receive further recognition for her contributions to neurology and neuroscience research in the years to come.

Conclusion

Dr. Didem Tezen is a highly accomplished neurologist and researcher with a strong background in neuromuscular disorders, neurodegeneration, and neurogenetics. Her extensive research output, clinical expertise, and multidisciplinary approach make her a valuable asset to the field of neurology. Her contributions to biomarker discovery, genetic analysis, and electrophysiology have advanced our understanding of neurological diseases, earning her recognition among peers. While she has already established a strong foundation, further expanding her international collaborations, securing research funding, and increasing first-author publications could elevate her to greater scientific prominence. Overall, Dr. Tezen is a deserving candidate for the Best Researcher Award, and her dedication to scientific excellence will continue to have a significant impact on neurology research and patient care.

Scientific Activities

  1. Tezen D, Koçhan Kızılkılıç E, Akkan Suzan A, et al. 2025.

    • Correlation between serum YKL-40 and VILIP 1 levels and brain volume in dementia patients.

  2. Tezen D, Khojakulov Z, Gündüz A, Deymeer F, Demirbilek V, Başak AN. 2024.

    • Clinical, electrophysiological, and genetic analysis of a family with two rare neuromuscular disorders: congenital myasthenic syndrome and hereditary polyneuropathy.

  3. Tezen D, Kızılkılıç EK, Erener N, Khojakulov Z, Demirbilek V, Başak AN. 2025.

    • Experience with salbutamol treatment in a family with congenital myasthenia due to CHRNE mutation.

  4. Tezen D, Savrun F. 2023.

    • Alt Motor Nöron Hastalıkları, in Türkiye Klinikleri Nöroloji Özel Sayı-Motor Nöron Hastalıkları, edited by Nurten Uzun Adatepe.

  5. Gulmammadli N, Konukoğlu D, Merve Kurtuluş E, Tezen D, Ibrahim Erbay M, Bozluolçay M. 2022.

    • Serum Sirtuin-1, HMGB1-TLR4, NF-KB and IL-6 levels in Alzheimer’s: The Relation Between Neuroinflammatory Pathway and Severity of Dementia.

  6. Tezen D, Gunduz A, Erdemir Kiziltan M, Yalcinkaya C, Kiziltan G. 2022.

    • ADCY5 gene mutation: a case report.

  7. Tezen D, Şimşir G, Çokar Ö, Demirbilek V, Başak AN, Yapıcı Z. 2022.

    • Four Turkish families with hyperekplexia: A missense mutation and the exon 1-7 deletion in the GLRA1 gene.

  8. Aktuglu Zeybek C, Gunduz A, Enver EO, Tezen D, Kiykim E, Kızıltan ME. 2020.

    • Movement disorders in the early-diagnosed cerebrotendinous xanthomatosis: An electrophysiological study.

  9. Benbir Şenel G, Tezen D, Tekgül Ş, Başak AN. 2020.

    • Co-existence of Mutations in PRRT2 and ABCC6 Genes in a Turkish Family.